Marked Pascal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

email article
Progress continues to be made on new transcatheter devices for the treatment of severe mitral and tricuspid regurgitation, investigators reported.
Several valve repair and replacement technologies, designed as alternatives to surgery in high-risk patients, had promising early results presented at this year s virtual European Association of Percutaneous Cardiovascular Interventions (EuroPCR) meeting.
The larger pivotal trials for these devices are not expected to be completed for at least another few years. As such, the following all remain investigational devices in the U.S.
Tendyne in Mitral Valve Replacement
Operators reported good real-world experience with Tendyne, a tri-leaflet bioprosthetic valve from Abbott, in registry data going out to 30 days. ....

Nicole Lou , Edwards Lifesciences , Abbott Triclip , York Heart Association , Peuropean Association Of Percutaneous Cardiovascular Interventions Euro , European Association , Percutaneous Cardiovascular Interventions , Mitral Valve , New York Heart Association , Marked Pascal , Pascal Ace , Tricuspid Valve , Medpage Today , Tricuspid Regurgitation , Tricuspid Valve Stenosis , Medical Therapy , நிக்கோல் லூ , எட்வர்ட்ஸ் ஆயுள் அறிவியல் , யார்க் இதயம் சங்கம் , ஐரோப்பிய சங்கம் , மிட்ரல் அடைப்பான் , புதியது யார்க் இதயம் சங்கம் , மருத்துவ சிகிச்சை ,